Boston Scientific’s Taxus Express2 To Make Long-Awaited Debut In Japan
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific expects to launch its Taxus Express2 paclitaxel-eluting stent in Japan in four to six weeks, once the Japanese Ministry of Health, Labor and Welfare establishes reimbursement for the device
You may also be interested in...
Taxus launch in Japan
Boston Scientific launches its Taxus Express2 paclitaxel-eluting stent in Japan May 8. The firm secured reimbursement from Japan's National Health Insurance System May 1 for the device, which gained Ministry of Health, Labor and Welfare approval in late March. Taxus joins Johnson & Johnson/Cordis' Cypher, the only drug-eluting stent on the Japanese market (1"The Gray Sheet" April 9, 2007, p. 17)...
Taxus launch in Japan
Boston Scientific launches its Taxus Express2 paclitaxel-eluting stent in Japan May 8. The firm secured reimbursement from Japan's National Health Insurance System May 1 for the device, which gained Ministry of Health, Labor and Welfare approval in late March. Taxus joins Johnson & Johnson/Cordis' Cypher, the only drug-eluting stent on the Japanese market (1"The Gray Sheet" April 9, 2007, p. 17)...
Abbott’s SPIRITs Are Raised By Positive Drug-Eluting Stent Data At ACC
Abbott's SPIRIT III trial for its Xience V everolimus-eluting stent bodes well for the device's market potential and points to a new direction for stent manufacturers' premarket relationship with FDA